Department of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul, Korea
1Laboratory of Radiation Pathology, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul, Korea
© 2018 The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Histological diagnosis | No. of cases (%) | |
---|---|---|
FN | FA | 27 (23) |
FC | 23 (20) | |
HC | 1 (1) | |
Non-FN | FVPTC | 35 (30) |
PTC | 12 (10) | |
NH | 17 (15) | |
HT | 1 (1) |
Histological diagnosis | Greaves et al. (2000) [6] | Deveci et al. (2006) [7] | Wu et al. (2012) [8] | Faquin (2009) [9] | Yang et al. (2007) [10] |
---|---|---|---|---|---|
FA | 25/96 (26) | 145/339 (43) | 35/65 (54) | 88/251 (35) | 109/326 (33) |
FC | 6/96 (6) | 21/339 (6) | 5/65 (8) | 22/251 (9) | 16/326 (5) |
HA | NA | NA | NA | NA | 48/326 (15) |
HC | NA | 9/339 (3) | NA | NA | 13/326 (4) |
FVPTC | 6/96 (6) | 36/339 (11) | 7/65 (11) | 40/251 (16) | 71/326 (22) |
PTC | 16/96 (17) | 8/339 (2) | 1/65 (1.5) | NA | NA |
NH | 36/96 (38) | 120/339 (35) | 16/65 (24) | 100/251 (40) | 53/326 (16) |
HT | 6/96 (6) | NA | NA | NA | 11/326 (3) |
Other malignancy | 1/96 (1) | NA | NA | 1/251 (0.3) | 5/326 (2) |
Values are presented as number (%).
FA, follicular adenoma; FC, follicular carcinoma; HA, Hurthle cell adenoma; NA, not applicable; HC, Hurthle cell carcinoma; FVPTC, follicular variant of papillary thyroid carcinoma; PTC, classic papillary thyroid carcinoma; NH, nodular hyperplasia; HT, Hashimoto thyroiditis.
Histological diagnosis | No. of cases (%) | |
---|---|---|
FN | FA | 27 (23) |
FC | 23 (20) | |
HC | 1 (1) | |
Non-FN | FVPTC | 35 (30) |
PTC | 12 (10) | |
NH | 17 (15) | |
HT | 1 (1) |
Histological diagnosis | Cytological architecture |
||||
---|---|---|---|---|---|
Microfollicular pattern | Multilayer rosettes | Trabecular pattern | Branching monolayer sheets | Syncytial fragments | |
FA (n = 27) | 27 (100) | 4 (15) | 9 (33) | 3 (11) | 26 (96) |
FC (n = 23) | 23 (100) | 8 (35) | 8 (35) | 1 (4) | 22 (96) |
HC (n = 1) | 1 (100) | 0 | 0 | 0 | 0 |
FVPTC (n = 35) | 33 (94) | 16 (46) | 0 | 12 (34) | 30 (86) |
PTC (n = 12) | 10 (83) | 5 (42) | 0 | 0 | 12 (100) |
NH (n = 17) | 17 (100) | 1 (6) | 0 | 3 (17) | 11 (65) |
HT (n = 1) | 1 (100) | 0 | 0 | 0 | 1 (100) |
Total (n = 116) | 112 (97) | 34 (29) | 17 (15) | 19 (16) | 101 (87) |
Histological diagnosis | Nuclear characteristic |
|||
---|---|---|---|---|
Chromatin clearing | Nuclear groove | Intranuclear cytoplasmic inclusion | Anisonucleosis | |
FA (n = 27) | 1 (4) | 11 (41) | 2 (7) | 7 (26) |
FC (n = 23) | 4 (17) | 5 (22) | 3 (13) | 20 (87) |
HC (n = 1) | 0 | 1 (100) | 0 | 0 |
FVPTC (n = 35) | 30 (86) | 32 (91) | 17 (49) | 32 (91) |
PTC (n = 12) | 9 (75) | 4 (33) | 2 (17) | 10 (83) |
NH (n = 17) | 0 | 8 (47) | 1 (6) | 4 (24) |
HT (n = 1) | 0 | 0 | 0 | 1 (100) |
Histological diagnosis | Round | Round-to-oval | Oval-to-elongated |
---|---|---|---|
FA (n = 27) | 19 (70) | 8 (30) | 0 |
FC (n = 23) | 21 (91) | 2 (9) | 0 |
HC (n = 1) | 1 (100) | 0 | 0 |
FVPTC (n = 35) | 15 (43) | 7 (20) | 13 (37) |
PTC (n = 12) | 9 (75) | 3 (25) | 0 |
NH (n = 17) | 16 (94) | 1 (6) | 0 |
HT (n = 1) | 1 (100) | 0 | 0 |
FN (n = 51) | Non-FN (n = 65) | χ2 | p-value | |
---|---|---|---|---|
Cytological architecture | ||||
Microfollicular pattern | .071 | |||
Present | 51 (100) | 61 (94) | 3.251 | |
Absent | 0 | 4 (6) | ||
Multilayer rosettes | .226 | |||
Present | 12 (24) | 22 (34) | 1.468 | |
Absent | 39 (76) | 43 (66) | ||
Trabecular pattern | < .001 | |||
Present | 17 (33) | 0 | 22.037 | |
Absent | 34 (67) | 65 (100) | ||
Branching monolayer sheets | ||||
Present | 4 (8) | 15 (23) | 4.842 | .028 |
Absent | 47 (92) | 50 (77) | ||
Syncytial fragments | ||||
Present | 48 (94) | 54 (83) | 3.283 | .070 |
Absent | 3 (6) | 11 (17) | ||
Nuclear characteristics | ||||
Chromatin clearing | < .001 | |||
Present | 5 (10) | 39 (60) | 30.584 | |
Absent | 46 (90) | 26 (40) | ||
Nuclear groove | < .001 | |||
Present | 17 (33) | 44 (68) | 13.531 | |
Absent | 34 (67) | 21 (32) | ||
Intranuclear cytoplasmic inclusion | ||||
Present | 5 (10) | 20 (32) | 7.430 | .006 |
Absent | 46 (90) | 45 (68) | ||
Anisonucleosis | .048 | |||
Present | 27 (53) | 46 (71) | 3.894 | |
Absent | 24 (47) | 19 (29) |
NIFTP (n = 20) | Invasive EFVPTC (n = 12) | Infiltrative FVPTC (n = 3) | p-value for NIFPT vs infiltrative FVPTC | p-value for NIFPT vs infiltrative | p-value for invasive EFVPTC vs infiltrative FVPTC | |
---|---|---|---|---|---|---|
Microfollicular pattern | .619 | .104 | .038 | |||
Present | 19 (95) | 12 (100) | 2 (67) | |||
Absent | 1 (5) | 0 (0) | 1 (33) | |||
Multilayer rosettes | .305 | .385 | .605 | |||
Present | 8 (40) | 6 (50) | 2 (67) | |||
Absent | 12 (60) | 6 (50) | 1 (33) | |||
Trabecular pattern | - | - | - | |||
Present | 0 | 0 | 0 | |||
Absent | 20 (100) | 12 (100) | 3 (100) | |||
Branching monolayer sheets | .039 | .214 | .292 | |||
Present | 6 (30) | 4 (33) | 2 (67) | |||
Absent | 14 (70) | 8 (67) | 1 (33) | |||
Syncytial fragments | .016 | .472 | .448 | |||
Present | 17 (85) | 10 (83) | 3 (100) | |||
Absent | 3 (15) | 2 (17) | 0 | |||
Chromatin clearing | .059 | .328 | - | |||
Present | 15 (75) | 12 (100) | 3 (100) | |||
Absent | 5 (25) | 0 | 0 | |||
Nuclear groove | .876 | .567 | .605 | |||
Present | 18 (90) | 11 (92) | 3 (100) | |||
Absent | 2 (10) | 1 (8) | 0 | |||
Intranuclear cytoplasmic inclusion | .465 | .484 | .792 | |||
Present | 11 (50) | 5 (42) | 1 (33) | |||
Absent | 9 (45) | 7 (58) | 2 (67) | |||
Anisonucleosis | .876 | .567 | .605 | |||
Present | 18 (90) | 11 (92) | 3 (100) | |||
Absent | 2 (10) | 1 (8) | 0 |
Histological diagnosis | Greaves et al. (2000) [6] | Deveci et al. (2006) [7] | Wu et al. (2012) [8] | Faquin (2009) [9] | Yang et al. (2007) [10] |
---|---|---|---|---|---|
FA | 25/96 (26) | 145/339 (43) | 35/65 (54) | 88/251 (35) | 109/326 (33) |
FC | 6/96 (6) | 21/339 (6) | 5/65 (8) | 22/251 (9) | 16/326 (5) |
HA | NA | NA | NA | NA | 48/326 (15) |
HC | NA | 9/339 (3) | NA | NA | 13/326 (4) |
FVPTC | 6/96 (6) | 36/339 (11) | 7/65 (11) | 40/251 (16) | 71/326 (22) |
PTC | 16/96 (17) | 8/339 (2) | 1/65 (1.5) | NA | NA |
NH | 36/96 (38) | 120/339 (35) | 16/65 (24) | 100/251 (40) | 53/326 (16) |
HT | 6/96 (6) | NA | NA | NA | 11/326 (3) |
Other malignancy | 1/96 (1) | NA | NA | 1/251 (0.3) | 5/326 (2) |
FN, follicular neoplasm; FA, follicular adenoma; FC, follicular carcinoma; HC, Hurthle cell carcinoma; FVPTC, follicular variant of papillary thyroid carcinoma; PTC, classic papillary thyroid carcinoma; NH, nodular hyperplasia; HT, Hashimoto thyroiditis.
Values are presented as number (%). FA, follicular adenoma; FC, follicular carcinoma; HC, Hurthle cell carcinoma; FVPTC, follicular variant of papillary thyroid carcinoma; PTC, classic papillary thyroid carcinoma; NH, nodular hyperplasia; HT, Hashimoto thyroiditis.
Values are presented as number (%). FA, follicular adenoma; FC, follicular carcinoma; HC, Hurthle cell carcinoma; FVPTC, follicular variant of papillary thyroid carcinoma; PTC, classic papillary thyroid carcinoma; NH, nodular hyperplasia; HT, Hashimoto thyroiditis.
Values are presented as number (%). FA, follicular adenoma; FC, follicular carcinoma; HC, Hurthle cell carcinoma; FVPTC, follicular variant of papillary thyroid carcinoma; PTC, classic papillary thyroid carcinoma; NH, nodular hyperplasia; HT, Hashimoto thyroiditis.
Values are presented as number (%). FN, follicular neoplasm; Non-FN, disease other than FN.
Values are presented as number (%). FVPTC, follicular variant of papillary carcinoma; NIFTP, noninvasive follicular thyroid neoplasm with papillary-like nuclear feature; EFVPTC, encapsulated follicular variant of papillary carcinoma.
Values are presented as number (%). FA, follicular adenoma; FC, follicular carcinoma; HA, Hurthle cell adenoma; NA, not applicable; HC, Hurthle cell carcinoma; FVPTC, follicular variant of papillary thyroid carcinoma; PTC, classic papillary thyroid carcinoma; NH, nodular hyperplasia; HT, Hashimoto thyroiditis.